Global Interleukin 2 Receptor Subunit Alpha Market Growth 2025-2031

January 2025 | 80 pages | ID: GB2FD2EB903EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Interleukin 2 Receptor Subunit Alpha market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Interleukin 2 Receptor Subunit Alpha is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Interleukin 2 Receptor Subunit Alpha is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Interleukin 2 Receptor Subunit Alpha is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Interleukin 2 Receptor Subunit Alpha players cover AbbVie Inc., Alkermes Plc, APT Therapeutics, Inc., Mabtech Limited, Philogen S.p.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Interleukin 2 Receptor Subunit Alpha Industry Forecast” looks at past sales and reviews total world Interleukin 2 Receptor Subunit Alpha sales in 2024, providing a comprehensive analysis by region and market sector of projected Interleukin 2 Receptor Subunit Alpha sales for 2025 through 2031. With Interleukin 2 Receptor Subunit Alpha sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interleukin 2 Receptor Subunit Alpha industry.

This Insight Report provides a comprehensive analysis of the global Interleukin 2 Receptor Subunit Alpha landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interleukin 2 Receptor Subunit Alpha portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Interleukin 2 Receptor Subunit Alpha market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interleukin 2 Receptor Subunit Alpha and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interleukin 2 Receptor Subunit Alpha.

This report presents a comprehensive overview, market shares, and growth opportunities of Interleukin 2 Receptor Subunit Alpha market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • DEL-106
  • MDNA-209
  • NKTR-358
  • APT-602
  • Others
Segmentation by Application:
  • Autoimmune Disorders
  • Blood Cancer
  • Ovarian Cancer
  • Renal Cell Carcinoma
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • AbbVie Inc.
  • Alkermes Plc
  • APT Therapeutics, Inc.
  • Mabtech Limited
  • Philogen S.p.A.
Key Questions Addressed in this Report

What is the 10-year outlook for the global Interleukin 2 Receptor Subunit Alpha market?

What factors are driving Interleukin 2 Receptor Subunit Alpha market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Interleukin 2 Receptor Subunit Alpha market opportunities vary by end market size?

How does Interleukin 2 Receptor Subunit Alpha break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Interleukin 2 Receptor Subunit Alpha Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Interleukin 2 Receptor Subunit Alpha by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Interleukin 2 Receptor Subunit Alpha by Country/Region, 2020, 2024 & 2031
2.2 Interleukin 2 Receptor Subunit Alpha Segment by Type
  2.2.1 DEL-106
  2.2.2 MDNA-209
  2.2.3 NKTR-358
  2.2.4 APT-602
  2.2.5 Others
2.3 Interleukin 2 Receptor Subunit Alpha Sales by Type
  2.3.1 Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Type (2020-2025)
  2.3.2 Global Interleukin 2 Receptor Subunit Alpha Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Interleukin 2 Receptor Subunit Alpha Sale Price by Type (2020-2025)
2.4 Interleukin 2 Receptor Subunit Alpha Segment by Application
  2.4.1 Autoimmune Disorders
  2.4.2 Blood Cancer
  2.4.3 Ovarian Cancer
  2.4.4 Renal Cell Carcinoma
  2.4.5 Others
2.5 Interleukin 2 Receptor Subunit Alpha Sales by Application
  2.5.1 Global Interleukin 2 Receptor Subunit Alpha Sale Market Share by Application (2020-2025)
  2.5.2 Global Interleukin 2 Receptor Subunit Alpha Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Interleukin 2 Receptor Subunit Alpha Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Interleukin 2 Receptor Subunit Alpha Breakdown Data by Company
  3.1.1 Global Interleukin 2 Receptor Subunit Alpha Annual Sales by Company (2020-2025)
  3.1.2 Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Company (2020-2025)
3.2 Global Interleukin 2 Receptor Subunit Alpha Annual Revenue by Company (2020-2025)
  3.2.1 Global Interleukin 2 Receptor Subunit Alpha Revenue by Company (2020-2025)
  3.2.2 Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Company (2020-2025)
3.3 Global Interleukin 2 Receptor Subunit Alpha Sale Price by Company
3.4 Key Manufacturers Interleukin 2 Receptor Subunit Alpha Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Interleukin 2 Receptor Subunit Alpha Product Location Distribution
  3.4.2 Players Interleukin 2 Receptor Subunit Alpha Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INTERLEUKIN 2 RECEPTOR SUBUNIT ALPHA BY GEOGRAPHIC REGION

4.1 World Historic Interleukin 2 Receptor Subunit Alpha Market Size by Geographic Region (2020-2025)
  4.1.1 Global Interleukin 2 Receptor Subunit Alpha Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Interleukin 2 Receptor Subunit Alpha Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Interleukin 2 Receptor Subunit Alpha Market Size by Country/Region (2020-2025)
  4.2.1 Global Interleukin 2 Receptor Subunit Alpha Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Interleukin 2 Receptor Subunit Alpha Annual Revenue by Country/Region (2020-2025)
4.3 Americas Interleukin 2 Receptor Subunit Alpha Sales Growth
4.4 APAC Interleukin 2 Receptor Subunit Alpha Sales Growth
4.5 Europe Interleukin 2 Receptor Subunit Alpha Sales Growth
4.6 Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales Growth

5 AMERICAS

5.1 Americas Interleukin 2 Receptor Subunit Alpha Sales by Country
  5.1.1 Americas Interleukin 2 Receptor Subunit Alpha Sales by Country (2020-2025)
  5.1.2 Americas Interleukin 2 Receptor Subunit Alpha Revenue by Country (2020-2025)
5.2 Americas Interleukin 2 Receptor Subunit Alpha Sales by Type (2020-2025)
5.3 Americas Interleukin 2 Receptor Subunit Alpha Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Interleukin 2 Receptor Subunit Alpha Sales by Region
  6.1.1 APAC Interleukin 2 Receptor Subunit Alpha Sales by Region (2020-2025)
  6.1.2 APAC Interleukin 2 Receptor Subunit Alpha Revenue by Region (2020-2025)
6.2 APAC Interleukin 2 Receptor Subunit Alpha Sales by Type (2020-2025)
6.3 APAC Interleukin 2 Receptor Subunit Alpha Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Interleukin 2 Receptor Subunit Alpha by Country
  7.1.1 Europe Interleukin 2 Receptor Subunit Alpha Sales by Country (2020-2025)
  7.1.2 Europe Interleukin 2 Receptor Subunit Alpha Revenue by Country (2020-2025)
7.2 Europe Interleukin 2 Receptor Subunit Alpha Sales by Type (2020-2025)
7.3 Europe Interleukin 2 Receptor Subunit Alpha Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Interleukin 2 Receptor Subunit Alpha by Country
  8.1.1 Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Interleukin 2 Receptor Subunit Alpha Revenue by Country (2020-2025)
8.2 Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales by Type (2020-2025)
8.3 Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interleukin 2 Receptor Subunit Alpha
10.3 Manufacturing Process Analysis of Interleukin 2 Receptor Subunit Alpha
10.4 Industry Chain Structure of Interleukin 2 Receptor Subunit Alpha

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Interleukin 2 Receptor Subunit Alpha Distributors
11.3 Interleukin 2 Receptor Subunit Alpha Customer

12 WORLD FORECAST REVIEW FOR INTERLEUKIN 2 RECEPTOR SUBUNIT ALPHA BY GEOGRAPHIC REGION

12.1 Global Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Region
  12.1.1 Global Interleukin 2 Receptor Subunit Alpha Forecast by Region (2026-2031)
  12.1.2 Global Interleukin 2 Receptor Subunit Alpha Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Interleukin 2 Receptor Subunit Alpha Forecast by Type (2026-2031)
12.7 Global Interleukin 2 Receptor Subunit Alpha Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 AbbVie Inc.
  13.1.1 AbbVie Inc. Company Information
  13.1.2 AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
  13.1.3 AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 AbbVie Inc. Main Business Overview
  13.1.5 AbbVie Inc. Latest Developments
13.2 Alkermes Plc
  13.2.1 Alkermes Plc Company Information
  13.2.2 Alkermes Plc Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
  13.2.3 Alkermes Plc Interleukin 2 Receptor Subunit Alpha Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Alkermes Plc Main Business Overview
  13.2.5 Alkermes Plc Latest Developments
13.3 APT Therapeutics, Inc.
  13.3.1 APT Therapeutics, Inc. Company Information
  13.3.2 APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
  13.3.3 APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 APT Therapeutics, Inc. Main Business Overview
  13.3.5 APT Therapeutics, Inc. Latest Developments
13.4 Mabtech Limited
  13.4.1 Mabtech Limited Company Information
  13.4.2 Mabtech Limited Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
  13.4.3 Mabtech Limited Interleukin 2 Receptor Subunit Alpha Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Mabtech Limited Main Business Overview
  13.4.5 Mabtech Limited Latest Developments
13.5 Philogen S.p.A.
  13.5.1 Philogen S.p.A. Company Information
  13.5.2 Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
  13.5.3 Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Philogen S.p.A. Main Business Overview
  13.5.5 Philogen S.p.A. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Interleukin 2 Receptor Subunit Alpha Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Interleukin 2 Receptor Subunit Alpha Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DEL-106
Table 4. Major Players of MDNA-209
Table 5. Major Players of NKTR-358
Table 6. Major Players of APT-602
Table 7. Major Players of Others
Table 8. Global Interleukin 2 Receptor Subunit Alpha Sales byType (2020-2025) & (K Pcs)
Table 9. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share byType (2020-2025)
Table 10. Global Interleukin 2 Receptor Subunit Alpha Revenue byType (2020-2025) & ($ million)
Table 11. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share byType (2020-2025)
Table 12. Global Interleukin 2 Receptor Subunit Alpha Sale Price byType (2020-2025) & (USD/Pcs)
Table 13. Global Interleukin 2 Receptor Subunit Alpha Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Interleukin 2 Receptor Subunit Alpha Sale Market Share by Application (2020-2025)
Table 15. Global Interleukin 2 Receptor Subunit Alpha Revenue by Application (2020-2025) & ($ million)
Table 16. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Application (2020-2025)
Table 17. Global Interleukin 2 Receptor Subunit Alpha Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Interleukin 2 Receptor Subunit Alpha Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Company (2020-2025)
Table 20. Global Interleukin 2 Receptor Subunit Alpha Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Company (2020-2025)
Table 22. Global Interleukin 2 Receptor Subunit Alpha Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Interleukin 2 Receptor Subunit Alpha Producing Area Distribution and Sales Area
Table 24. Players Interleukin 2 Receptor Subunit Alpha Products Offered
Table 25. Interleukin 2 Receptor Subunit Alpha Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Interleukin 2 Receptor Subunit Alpha Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share Geographic Region (2020-2025)
Table 30. Global Interleukin 2 Receptor Subunit Alpha Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Interleukin 2 Receptor Subunit Alpha Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country/Region (2020-2025)
Table 34. Global Interleukin 2 Receptor Subunit Alpha Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Interleukin 2 Receptor Subunit Alpha Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2020-2025)
Table 38. Americas Interleukin 2 Receptor Subunit Alpha Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Interleukin 2 Receptor Subunit Alpha Sales byType (2020-2025) & (K Pcs)
Table 40. Americas Interleukin 2 Receptor Subunit Alpha Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Interleukin 2 Receptor Subunit Alpha Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Interleukin 2 Receptor Subunit Alpha Sales Market Share by Region (2020-2025)
Table 43. APAC Interleukin 2 Receptor Subunit Alpha Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Interleukin 2 Receptor Subunit Alpha Sales byType (2020-2025) & (K Pcs)
Table 45. APAC Interleukin 2 Receptor Subunit Alpha Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Interleukin 2 Receptor Subunit Alpha Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Interleukin 2 Receptor Subunit Alpha Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Interleukin 2 Receptor Subunit Alpha Sales byType (2020-2025) & (K Pcs)
Table 49. Europe Interleukin 2 Receptor Subunit Alpha Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales byType (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Interleukin 2 Receptor Subunit Alpha
Table 55. Key Market Challenges & Risks of Interleukin 2 Receptor Subunit Alpha
Table 56. Key IndustryTrends of Interleukin 2 Receptor Subunit Alpha
Table 57. Interleukin 2 Receptor Subunit Alpha Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Interleukin 2 Receptor Subunit Alpha Distributors List
Table 60. Interleukin 2 Receptor Subunit Alpha Customer List
Table 61. Global Interleukin 2 Receptor Subunit Alpha SalesForecast by Region (2026-2031) & (K Pcs)
Table 62. Global Interleukin 2 Receptor Subunit Alpha RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Interleukin 2 Receptor Subunit Alpha SalesForecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Interleukin 2 Receptor Subunit Alpha Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Interleukin 2 Receptor Subunit Alpha SalesForecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Interleukin 2 Receptor Subunit Alpha Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Interleukin 2 Receptor Subunit Alpha SalesForecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Interleukin 2 Receptor Subunit Alpha RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Interleukin 2 Receptor Subunit Alpha SalesForecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Interleukin 2 Receptor Subunit Alpha RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Interleukin 2 Receptor Subunit Alpha SalesForecast byType (2026-2031) & (K Pcs)
Table 72. Global Interleukin 2 Receptor Subunit Alpha RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Interleukin 2 Receptor Subunit Alpha SalesForecast by Application (2026-2031) & (K Pcs)
Table 74. Global Interleukin 2 Receptor Subunit Alpha RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. AbbVie Inc. Basic Information, Interleukin 2 Receptor Subunit Alpha Manufacturing Base, Sales Area and Its Competitors
Table 76. AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
Table 77. AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. AbbVie Inc. Main Business
Table 79. AbbVie Inc. Latest Developments
Table 80. Alkermes Plc Basic Information, Interleukin 2 Receptor Subunit Alpha Manufacturing Base, Sales Area and Its Competitors
Table 81. Alkermes Plc Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
Table 82. Alkermes Plc Interleukin 2 Receptor Subunit Alpha Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Alkermes Plc Main Business
Table 84. Alkermes Plc Latest Developments
Table 85. APTTherapeutics, Inc. Basic Information, Interleukin 2 Receptor Subunit Alpha Manufacturing Base, Sales Area and Its Competitors
Table 86. APTTherapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
Table 87. APTTherapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. APTTherapeutics, Inc. Main Business
Table 89. APTTherapeutics, Inc. Latest Developments
Table 90. Mabtech Limited Basic Information, Interleukin 2 Receptor Subunit Alpha Manufacturing Base, Sales Area and Its Competitors
Table 91. Mabtech Limited Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
Table 92. Mabtech Limited Interleukin 2 Receptor Subunit Alpha Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Mabtech Limited Main Business
Table 94. Mabtech Limited Latest Developments
Table 95. Philogen S.p.A. Basic Information, Interleukin 2 Receptor Subunit Alpha Manufacturing Base, Sales Area and Its Competitors
Table 96. Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Product Portfolios and Specifications
Table 97. Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Philogen S.p.A. Main Business
Table 99. Philogen S.p.A. Latest Developments



LIST OFFIGURES

Figure 1. Picture of Interleukin 2 Receptor Subunit Alpha
Figure 2. Interleukin 2 Receptor Subunit Alpha Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Interleukin 2 Receptor Subunit Alpha Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Interleukin 2 Receptor Subunit Alpha Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Interleukin 2 Receptor Subunit Alpha Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country/Region (2024)
Figure 10. Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of DEL-106
Figure 12. Product Picture of MDNA-209
Figure 13. Product Picture of NKTR-358
Figure 14. Product Picture of APT-602
Figure 15. Product Picture of Others
Figure 16. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share byType in 2025
Figure 17. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share byType (2020-2025)
Figure 18. Interleukin 2 Receptor Subunit Alpha Consumed in Autoimmune Disorders
Figure 19. Global Interleukin 2 Receptor Subunit Alpha Market: Autoimmune Disorders (2020-2025) & (K Pcs)
Figure 20. Interleukin 2 Receptor Subunit Alpha Consumed in Blood Cancer
Figure 21. Global Interleukin 2 Receptor Subunit Alpha Market: Blood Cancer (2020-2025) & (K Pcs)
Figure 22. Interleukin 2 Receptor Subunit Alpha Consumed in Ovarian Cancer
Figure 23. Global Interleukin 2 Receptor Subunit Alpha Market: Ovarian Cancer (2020-2025) & (K Pcs)
Figure 24. Interleukin 2 Receptor Subunit Alpha Consumed in Renal Cell Carcinoma
Figure 25. Global Interleukin 2 Receptor Subunit Alpha Market: Renal Cell Carcinoma (2020-2025) & (K Pcs)
Figure 26. Interleukin 2 Receptor Subunit Alpha Consumed in Others
Figure 27. Global Interleukin 2 Receptor Subunit Alpha Market: Others (2020-2025) & (K Pcs)
Figure 28. Global Interleukin 2 Receptor Subunit Alpha Sale Market Share by Application (2024)
Figure 29. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Application in 2025
Figure 30. Interleukin 2 Receptor Subunit Alpha Sales by Company in 2025 (K Pcs)
Figure 31. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Company in 2025
Figure 32. Interleukin 2 Receptor Subunit Alpha Revenue by Company in 2025 ($ millions)
Figure 33. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Company in 2025
Figure 34. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Interleukin 2 Receptor Subunit Alpha Sales 2020-2025 (K Pcs)
Figure 37. Americas Interleukin 2 Receptor Subunit Alpha Revenue 2020-2025 ($ millions)
Figure 38. APAC Interleukin 2 Receptor Subunit Alpha Sales 2020-2025 (K Pcs)
Figure 39. APAC Interleukin 2 Receptor Subunit Alpha Revenue 2020-2025 ($ millions)
Figure 40. Europe Interleukin 2 Receptor Subunit Alpha Sales 2020-2025 (K Pcs)
Figure 41. Europe Interleukin 2 Receptor Subunit Alpha Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales 2020-2025 (K Pcs)
Figure 43. Middle East & Africa Interleukin 2 Receptor Subunit Alpha Revenue 2020-2025 ($ millions)
Figure 44. Americas Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country in 2025
Figure 45. Americas Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Country (2020-2025)
Figure 46. Americas Interleukin 2 Receptor Subunit Alpha Sales Market Share byType (2020-2025)
Figure 47. Americas Interleukin 2 Receptor Subunit Alpha Sales Market Share by Application (2020-2025)
Figure 48. United States Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Interleukin 2 Receptor Subunit Alpha Sales Market Share by Region in 2025
Figure 53. APAC Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Region (2020-2025)
Figure 54. APAC Interleukin 2 Receptor Subunit Alpha Sales Market Share byType (2020-2025)
Figure 55. APAC Interleukin 2 Receptor Subunit Alpha Sales Market Share by Application (2020-2025)
Figure 56. China Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 60. India Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 62. ChinaTaiwan Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country in 2025
Figure 64. Europe Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Country (2020-2025)
Figure 65. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share byType (2020-2025)
Figure 66. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share by Application (2020-2025)
Figure 67. Germany Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 68.France Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share byType (2020-2025)
Figure 74. Middle East & Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share by Application (2020-2025)
Figure 75. Egypt Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 78.Turkey Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Interleukin 2 Receptor Subunit Alpha Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Interleukin 2 Receptor Subunit Alpha in 2025
Figure 81. Manufacturing Process Analysis of Interleukin 2 Receptor Subunit Alpha
Figure 82. Industry Chain Structure of Interleukin 2 Receptor Subunit Alpha
Figure 83. Channels of Distribution
Figure 84. Global Interleukin 2 Receptor Subunit Alpha Sales MarketForecast by Region (2026-2031)
Figure 85. Global Interleukin 2 Receptor Subunit Alpha Revenue Market ShareForecast by Region (2026-2031)
Figure 86. Global Interleukin 2 Receptor Subunit Alpha Sales Market ShareForecast byType (2026-2031)
Figure 87. Global Interleukin 2 Receptor Subunit Alpha Revenue Market ShareForecast byType (2026-2031)
Figure 88. Global Interleukin 2 Receptor Subunit Alpha Sales Market ShareForecast by Application (2026-2031)
Figure 89. Global Interleukin 2 Receptor Subunit Alpha Revenue Market ShareForecast by Application (2026-2031)